China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China
· Delayed Price · Currency is CNY 23.98
-0.01 (-0.04%)
Apr 29, 2026, 3:00 PM CST
SHA:600750 Revenue
China Resources Jiangzhong Pharmaceutical Co.,Ltd had revenue of 1.04B CNY in the quarter ending March 31, 2026, a decrease of -12.49%. This brings the company's revenue in the last twelve months to 4.07B, down -6.31% year-over-year. In the year 2025, China Resources Jiangzhong Pharmaceutical Co.,Ltd had annual revenue of 4.22B, down -4.87%.
Revenue (ttm)
4.07B
Revenue Growth
-6.31%
P/S Ratio
3.71
Revenue / Employee
935.56K
Employees
4,352
Market Cap
15.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.22B | -215.95M | -4.87% |
| Dec 31, 2024 | 4.44B | -117.76M | -2.59% |
| Dec 31, 2023 | 4.55B | 668.03M | 17.19% |
| Dec 31, 2022 | 3.89B | 1.01B | 35.19% |
| Dec 31, 2021 | 2.87B | 432.52M | 17.72% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Kangtai Biological Products | 2.66B |
| Shanghai Haoyuan Chemexpress | 2.88B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |
| Guangdong Zhongsheng Pharmaceutical | 2.45B |
| Shenzhen Hepalink Pharmaceutical Group | 5.48B |
| Shandong Buchang Pharmaceuticals | 10.96B |
| ApicHope Pharmaceutical Group | 940.78M |
| Beijing Aosaikang Pharmaceutical | 1.83B |